发明名称 Therapeutic agent for glaucoma comprising rho kinase inhibitor and prostaglandin
摘要 <p>A subject of the present invention is to find utility of a combination of a Rho kinase inhibitor and prostaglandins as a therapeutic agent for glaucoma. Actions of reducing intraocular pressure are complemented and/or enhanced each other by combining the Rho kinase inhibitor with prostaglandins. For the administration mode, each drug can be administered in combination or in mixture.</p>
申请公布号 EP2314299(A1) 申请公布日期 2011.04.27
申请号 EP20100192265 申请日期 2003.08.29
申请人 SANTEN PHARMACEUTICAL CO., LTD 发明人 NAKAJIMA, TADASHI;MATSUGI, TAKESHI;HARA, HIDEAKI
分类号 A61K31/5575;A61K31/437;A61K31/4409;A61K31/4725;A61K31/5377;A61K31/553;A61K45/06;A61P27/06;A61P43/00 主分类号 A61K31/5575
代理机构 代理人
主权项
地址